DYNAVAX TECHNOLOGIES CORPORATION MANAGEMENT CONTINUITY AND SEVERANCE AGREEMENTManagement Continuity and Severance Agreement • August 3rd, 2023 • Dynavax Technologies Corp • Pharmaceutical preparations • California
This Management Continuity and Severance Agreement (the “Agreement”) is dated as of [______, 20__], by and between [________________] (“Employee”) and Dynavax Technologies Corporation, a Delaware corporation (the “Company”).
Amendment No. 3 to Supply AgreementSupply Agreement • August 3rd, 2023 • Dynavax Technologies Corp • Pharmaceutical preparations
This Amendment No. 3, (“Amendment No. 3”) effective as of 26 April 2023 (the “Effective Date”) amends that certain Supply Agreement having an effective date of 1 July 2021, as amended to date (the “Agreement”) and is made by and between the parties hereto (each a “Party” and collectively the “Parties”).
Waiver and Second Amendment to AgreementAgreement • August 3rd, 2023 • Dynavax Technologies Corp • Pharmaceutical preparations
This Waiver and Second Amendment to Agreement (“Second Amendment”) is entered into and effective as of the date of last signature below (the “Second Amendment Date”), by and between Coalition for Epidemic Preparedness Innovations, having an address of PO Box 123, Torshov, N-0412 Oslo, Norway (“CEPI”), and Dynavax Technologies Corporation, having an address of 2100 Powell Street, Suite 720, Emeryville, CA 94608, USA (“Dynavax”).
